Cite
MLA Citation
P. Stachura et al.. “P345: AN IMMUNE SCREEN IDENTIFIES 5-NONLOXYTRYPTAMINE AS A NOVEL ANTI-CANCER AGENT CAPABLE OF IMPROVING ANTI-TUMOR IMMUNITY IN COMBINATION WITH ANTI-PD1 THERAPY.” HemaSphere, vol. 6, n.d., pp. 245–246. http://access.bl.uk/ark:/81055/vdc_100158014036.0x00000c